As president and CEO of Mass General Brigham, Dr. Klibanski leads a system with internationally known Brigham and Women’s Hospital and Massachusetts General Hospital, recognized specialty hospitals Mass Eye and Ear, McLean and Spaulding Rehabilitation, community hospitals, health centers and home-based care. It is the largest private employer in Massachusetts with 82,000 employees and $23 billion in annual revenue. Since her appointment in 2019, Dr. Klibanski led the transformation into a fully integrated academic health system, achieving greater clinical integration across its hospitals with multidisciplinary, disease-focused institutes, especially in heart and vascular, cancer and neuroscience. She expanded digital and virtual care and deepened investment in breakthrough research, including gene and cell therapies, supported by $2.9 billion in annual research and academic funding. She championed innovation, fueling the creation of over 300 health companies revolutionizing diagnostics, therapeutics and medical technology. She drives bold investments in AI to improve outcomes, reduce caregiver burden, enhance medical education and accelerate discovery from bench to bedside. A strong advocate for equity, Dr. Klibanski launched “United Against Racism,” a multiyear systemwide initiative to address health disparities and promote inclusion. An internationally recognized neuroendocrinologist, Dr. Klibanski previously served as Mass General Brigham’s chief academic officer and chief of neuroendocrine at Massachusetts General Hospital.
